Your browser doesn't support javascript.
loading
Understanding the Symptoms and Impacts Experienced by People with Relapsing-Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews.
Barrett, Amy; Olayinka-Amao, Oyebimpe; Ziemssen, Tjalf; Bharadia, Trishna; Henke, Christian; Kamudoni, Paul.
Afiliación
  • Barrett A; Patient-Centered Outcomes Assessment, RTI Health Solutions, Research Triangle Park, NC, USA.
  • Olayinka-Amao O; Patient-Centered Outcomes Assessment, RTI Health Solutions, Research Triangle Park, NC, USA.
  • Ziemssen T; Center of Clinical Neuroscience, Neurological Clinic, University Clinic Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Bharadia T; Patient Author, Buckinghamshire, UK.
  • Henke C; Merck Healthcare KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany.
  • Kamudoni P; Merck Healthcare KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany. paul.kamudoni@merckgroup.com.
Neurol Ther ; 13(2): 449-464, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38345742
ABSTRACT

INTRODUCTION:

Multiple sclerosis (MS) is a disabling disease with unpredictable clinical manifestations. As clinical assessments may not fully capture the impact of MS on quality of life, they can be complemented by patient-reported outcome (PRO) measures to provide a more comprehensive picture of MS disease state and impact. The objectives of this study were to explore the experiences of people with relapsing-remitting MS, including symptoms and impacts on daily life, and to provide a conceptual model of MS outcomes.

METHODS:

A literature review of studies that evaluated the experiences of people with MS was completed and combined with semi-structured concept elicitation interviews conducted with 14 people with relapsing-remitting MS in the USA.

RESULTS:

The average age of the 14 participants was 43.9 (range 25-64) years, most were White (78.6%) and female (78.6%), and the mean duration since diagnosis was 6.6 (2-10) years. The most bothersome symptoms identified included fatigue (n = 9), cognitive dysfunction (n = 5), mobility/difficulty with walking (n = 3), and vision problems (n = 3). The most commonly reported impacts on daily life were balance problems/instability (n = 13), work life/productivity (n = 12), difficulty walking (n = 11), daily activities/household chores (n = 11), and leisure activities (n = 10).

CONCLUSION:

There was a high frequency of concepts associated with physical function, fatigue, and sensory-motor actions. A conceptual model was developed that captures the disease symptoms, impairments, and impacts identified in the interviews as well as known processes and symptoms identified in the literature search. This model underpins the appropriateness of PRO instruments, such as the PROMIS Fatigue (MS) 8a and PROMIS Physical Function (MS) 15a, which evaluate symptoms and impacts that matter most to people with MS.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Neurol Ther Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Neurol Ther Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda